Solid Biosciences Cash from Investing (TTM) Analysis

Solid Biosciences Inc (SLDB)

8.38 -0.13 (-1.53%) USD | NASDAQ | May 22, 16:00

8.38 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	-66.06M
December 31, 2023	9.689M
September 30, 2023	30.49M
June 30, 2023	70.04M
March 31, 2023	58.67M
December 31, 2022	59.16M
September 30, 2022	23.23M
June 30, 2022	-64.19M
March 31, 2022	-53.31M
December 31, 2021	-91.09M
September 30, 2021	-121.32M
June 30, 2021	-48.89M
March 31, 2021	0.147M

Date	Value
December 31, 2020	6.60M
September 30, 2020	9.515M
June 30, 2020	13.56M
March 31, 2020	37.38M
December 31, 2019	24.52M
September 30, 2019	0.397M
June 30, 2019	-4.963M
March 31, 2019	-31.60M
December 31, 2018	-26.76M
September 30, 2018	-8.307M
June 30, 2018	-14.23M
March 31, 2018	1.875M
December 31, 2017	10.45M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-121.32M

Minimum

Sep 2021

70.04M

Maximum

Jun 2023

-5.321M

Average

8.058M

Median

Cash from Investing (TTM) Benchmarks